BMB Reports

Korean Society for Biochemistry and Molecular Biology (생화학분자생물학회)
권호 표지
DOI QR코드

DOI QR Code

Fragile-X Mental Retardation: Molecular Diagnosis in Argentine Patients

  • Florencia, Giliberto (Genetica y Biologia Molecular, Facultad de Farmacia y Bioquimica, Hospital de Clinicas, Universidad de Buenos Aires) ;
  • Irene, Szijan (Genetica y Biologia Molecular, Facultad de Farmacia y Bioquimica, Hospital de Clinicas, Universidad de Buenos Aires) ;
  • Veronica, Ferreiro (Genetica y Biologia Molecular, Facultad de Farmacia y Bioquimica, Hospital de Clinicas, Universidad de Buenos Aires)
  • Received : 2006.05.27
  • Accepted : 2006.07.28
  • Published : 2006.11.30
Download PDF
⟨ Previous Next ⟩

Abstract

Fragile-X-syndrome (FXS) is the most common type of inherited cognitive impairment. The underlying molecular alteration consists of a CGG-repeat amplification within the FMR-1 gene. The phenotype is only apparent once a threshold in the number of repeats has been exceeded (full mutation). The aim of this study was to characterize the FMR-1 CGG-repeat status in Argentine patients exhibiting mental retardation. A total of 330 blood samples from patients were analyzed by PCR and Southern blot analysis. Initially, DNA from 78 affected individuals were studied by PCR. Since this method is unable to detect high molecular weight alleles, however, we undertook a second approach using the Southern blotting technique to analyze the CGG repeat number and methylation status. Southern blot analysis showed an altered pattern in 14 out of 240 (6%) unrelated patients, with half of them presenting a mosaic pattern. Eight out of 17 families (47%) showed a (suggest deleting highlight). The characteristic FXS pattern was identified in 8/17 families (47%), and in 4 of these families 25% of the individuals presented with a mosaic model. The expansion from pre-mutation to full mutation was shown to occur both at the pre and post zygotic levels. The detection of FXS mutations has allowed us to offer more informed genetic counseling, prenatal diagnosis and reliable patient follow-up.

Keywords

References

  1. Abitbol, M., Menini, C., Delezoide, A. L., Rhyner, T., Vekemans, M. and Mallet, J. (1993) Nucleus basalis magnocellularis and hippocampus are the major sites of FMR-1 expression in the human fetal brain. Nat Genet. 4, 147-153 https://doi.org/10.1038/ng0693-147
  2. Allingham-Hawkins, D. J., Brown, C. A., Babul, R., Chitayat, D., Krekewich, K., Humphries, Ray, P. N. and Teshima, I. E. (1996) Tissue-specific methylation differences and cognitive function in fragile X premutation females. Am. J. Med. Genet. 64, 329-333 https://doi.org/10.1002/(SICI)1096-8628(19960809)64:2<329::AID-AJMG19>3.0.CO;2-H
  3. Bear, M. F., Huber, K. M. and Warren, S. T. (2004) The mGluR theory of fragile X mental retardation. Trends Neurosci. 27, 370-377 https://doi.org/10.1016/j.tins.2004.04.009
  4. Coffee, B., Zhang, F., Warren, S. T. and Reines, D. (1999) Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells. Nature Genet. 22, 98-101 https://doi.org/10.1038/8807
  5. Cohen, I. L., Nolin, S. L., Sudhalter, V., Ding, X. H., Dobkin, C. S. and Brown, W. T. (1996) Mosaicism for the FMR1 gene influences adaptive skills development in fragile X-affected males. Am. J. Med. Genet. 64, 365-369 https://doi.org/10.1002/(SICI)1096-8628(19960809)64:2<365::AID-AJMG26>3.0.CO;2-C
  6. Corbin, F., Bouillon, M., Fortin, A., Morin, S., Rousseau, F. and Khandjian, E. W. (1997) The fragile X mental retardation protein is associated with poly $(A)^+$ mRNA in actively translating polyribosomes. Hum. Mol. Genet. 8, 1465-1472
  7. De Boulle, K., Verkerk, A. J., Reyniers, E., Vits, L., Hendrickx, J., Van Roy, B., Den Bos, F. V., Graaff, E., Oostra, B. A. and Willems, P. J. (1993) A point mutation in the FMR-1 gene associated with fragile X mental retardation. Nature Genet. 3, 31-35 https://doi.org/10.1038/ng0193-31
  8. Dobkin, C. S., Nolin, S. L., Cohen, I., Sudhalter, V., Bialer, M. G., Ding, X. H. Jenkins, E. C., Zhong, N. and Brown, W. T. (1996) Tissue differences in fragile X mosaics: mosaicism in blood cells may differ greatly from skin. Am. J. Med. Genet. 64, 296-301 https://doi.org/10.1002/(SICI)1096-8628(19960809)64:2<296::AID-AJMG13>3.0.CO;2-A
  9. Feng, Y., Absher, D., Eberhart, D. E., Brown, V., Malter, H. E. and Warren, S. T. (1997) FMRP associates with polyribosomes as an mRNP and the I304N mutation of severe fragile X syndrome abolishes this association. Mol. Cell. 1, 109-118 https://doi.org/10.1016/S1097-2765(00)80012-X
  10. Gedeon, A. K., Baker, E., Robinson, H., Partington, M. W., Gross, B., Manca, A., Korn, B., Poustka, A., Yu, S., Sutherl, G. R. and Mulley, J. C. (1992) Fragile X syndrome without CCG amplification has an FMR1 deletion. Nature Genet. 1, 341-344 https://doi.org/10.1038/ng0892-341
  11. Genc, B., Muller-Hartmann, H., Zeschinig, M., Deissler, H., Schimtz, B., Majewski, F., Gontard, A. and Doerfler, W. (2000) Methylation mosaicism of 5'-(CGG)(n)-3' repeats in fragile X, premutation and normal individuals. Nucleic Acids Res. 28, 2141-2152 https://doi.org/10.1093/nar/28.10.2141
  12. Hagerman, R. J., Leehey, M., Heinrichs, W., Tassone, F., Wilson, R., Hills, J., Grigsby, J., Gage, B. and Hagerman, P. J. (2001) Intention tremor, parkinsonism and generalized brain atrophy in males carriers of fragile X. Neurology 57, 127-130 https://doi.org/10.1212/WNL.57.1.127
  13. Hilbert, P. and Sabine, M. (1996) Variation of CGG repeats at the fragil X site: clear signal enhancement using expand TM long template. Biochemica, 4, 29
  14. Hinds, H. L., Ashley, C. T., Sutcliffe, J. S., Nelson, D. L., Warren, S. T., Housman, D. E. and Schalling, M. (1993) Tissue specific expression of FMR-1 provides evidence for a functional role in fragile X syndrome. Nat. Genet. 3, 36-43 https://doi.org/10.1038/ng0193-36
  15. Kremer, E. J., Pritchard, M., Lynch, M., Yu, S., Holman, K., Baker, E., Warren, S. T., Schlessinger, D., Sutherland, G. R. and Richards, R. I. (1991) Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science 252, 1711-1714 https://doi.org/10.1126/science.1675488
  16. Laggerbauer, B., Ostareck, D., Keidel, E. M., Ostareck-Lederer, A. and Fischer, U. (2001) Evidence that fragile X mental retardation protein is a negative regulator of translation. Hum. Mol. Genet. 10, 329-338 https://doi.org/10.1093/hmg/10.4.329
  17. Li, Z., Zhang, Y., Ku, L., Wilkinson, K. D., Warren, S. T. and Feng, Y. (2001) The fragile X mental retardation protein inhibits translation via interacting with mRNA. Nucleic Acids Res. 29, 2276-2283 https://doi.org/10.1093/nar/29.11.2276
  18. Malter, H. E., Iber, J. C., Willemsen, R., de Graaff, E., Tarleton, J. C., Leisti, J., Warren, S. T. and Oostra, B. A. (1997) Characterization of the full fragile X syndrome mutation in fetal gamets. Nature Genet. 15, 165-169 https://doi.org/10.1038/ng0297-165
  19. Merenstein, S. A., Sobesky, W. E., Taylor, A. K., Riddle, J. E., Tran, H. X. and Hagerman R. J. (1996) Molecular-clinical correlations in males with an expanded FMR1 mutation. Am. J. Med. Genet. 64, 388-394 https://doi.org/10.1002/(SICI)1096-8628(19960809)64:2<388::AID-AJMG31>3.0.CO;2-9
  20. Moutou, C., Vincent, M. C., Blancalena, V. and Mandel, J. L. (1997) Transition from premutation to full mutation in fragile X sydrome is likely to be prezygotic. Hum. Mol. Genet. 6, 971-979 https://doi.org/10.1093/hmg/6.7.971
  21. Oberlé, I., Ruosseau, F., Heitz, D., Kretz, C., Devys, D., Hanauer, A., Boue, J., Bertheas, M. F. and Mandel, J. L. (1991) Instability of a 550-base pair DNA segment and abnormal methylation en fragil X syndrome. Science 252, 1097-1102 https://doi.org/10.1126/science.252.5009.1097
  22. Pearson, C. E. (2003) Slipping while slipping? Trinucleotide repeat expansions in germ cells. Trends Mol Med. 9, 490-495 https://doi.org/10.1016/j.molmed.2003.09.006
  23. Pearson, C. E., Edamura, K. N. and Cleary, J. D. (2005) Repeat instability: mechanisms of dynamic mutations. Nature Rev. Genet. 6, 729-742 https://doi.org/10.1038/nrg1689
  24. Pieretti, M., Zheng, F., Fu, Y. H., Warren, S. T., Oostra, B. A., Caskey, C. T. and Nelson, D. L. (1991) Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 66, 817-822 https://doi.org/10.1016/0092-8674(91)90125-I
  25. Reyniers, E., Martin, J. J., Cras, P., Van Marck, E., Handig, I., Jorens, H. Z., Oostra, B. A., Kooy, R. F. and Willems, P. J. (1999) Postmortem examination of two fragile X brothers with an FMR1 full mutation. Am. J. Med. Genet. 84, 245-249 https://doi.org/10.1002/(SICI)1096-8628(19990528)84:3<245::AID-AJMG16>3.0.CO;2-U
  26. Sherman, S. L., Jacobs, P. A., Morton, N. E., Froster-Iskenius. U., Howard-Peebles, P. N., Nielsen, K. B., Partington, M. W., Sutherland, G. R., Turner, G. and Watson, M. (1985) Further segregation analysis of the fragile X syndrome with special reference to transmitting males. Hum. Genet. 69, 289-299 https://doi.org/10.1007/BF00291644
  27. Tassone, F., Hagerman, R. J., Gane, L. W. and Taylor, A. K. (1999) Strong similarities of the FMR1 mutation in multiple tissues; postmortem studies of a male with a full mutation and a male carrier of a premutation. Am. J. Med. Genet. 84, 240-244 https://doi.org/10.1002/(SICI)1096-8628(19990528)84:3<240::AID-AJMG15>3.0.CO;2-B
  28. Taylor, A. K., Tassone, F., Dyer, P. N., Hersch, S. M., Harris, J. B., Greenough, W. T. and Hagerman, R. J. (1999) Tissue heterogeneity of the FMR1 mutation in a high-functioning male with fragile X syndrome. Am. J. Med. Genet. 84, 233-239 https://doi.org/10.1002/(SICI)1096-8628(19990528)84:3<233::AID-AJMG14>3.0.CO;2-6
  29. Verkerk, A. J. M. H., Graaff, E., De Boulle, K., Eichler, E.E., Konecki, D.S., Reyniers, E. et al. (1991) Identification of a gene (FMR-1) containing a CCG repeat coincident with a fragile X break point cluster region exhibing lengh variation in fragile X syndrome. Cell 65, 905-914 https://doi.org/10.1016/0092-8674(91)90397-H
  30. Warren, S. T. and Sherman, S. L. (2001) The fragile X syndrome; in The Metabolic and Molecular Basis of Inherited Disease, Saiver, C. R., Beaudet, A. L., Sly, W. S. and Valle, D. (eds.), pp. 1257-1289, Mc Graw Hill, New York, USA
  31. Wohrle, D., Kotzot, D., Hirst, M. C., Manca, A., Korn, B., Schmidt, A. et al. (1992) A microdeletion of less than 250 kb, including the proximal part of the FMR-1 gene and the fragile- X site, in a male with the clinical phenotype of fragile-X syndrome. Am. J. Hum. Genet. 51, 299-306

Cited by

  1. Open-label riluzole in fragile X syndrome vol.1380, 2011, https://doi.org/10.1016/j.brainres.2010.10.108
  2. Open-Label Memantine in Fragile X Syndrome vol.39, pp.12, 2009, https://doi.org/10.1007/s10803-009-0807-3
  3. FMR1 gene mutations in patients with fragile X syndrome and obligate carriers: 30 years of experience in Chile vol.98, 2016, https://doi.org/10.1017/S0016672316000082
  4. Molecular characterization of X chromosome fragility in idiopathic mental retardation vol.17, pp.2, 2016, https://doi.org/10.1016/j.ejmhg.2015.11.001